Author Information
Misako Matsumoto is a prominent researcher affiliated with the Department of Vaccine Immunology at Hokkaido University Graduate School of Medicine, located in Sapporo, Japan. Her work primarily focuses on the intersections of vaccine development, immunology, and the study of immune responses, particularly involving dendritic cells and toll-like receptors. Her research aims to advance understanding in vaccine immunology to improve therapeutic strategies against various diseases.Research Contributions
Misako Matsumoto has made significant contributions to the field of immunotherapy and vaccine development. Her research includes exploring the role of phospholipase A2 from bee venom in immune activation, targeting toll-like receptor 3 in dendritic cells for cancer immunotherapy, and investigating the potential of a toll-like receptor 3 agonist, ARNAX, for therapeutic immunotherapy. Her work also delves into the modulation of the tumor microenvironment with L-ergothioneine and the role of TICAM-1 in immune responses. Matsumoto's research is pivotal in understanding the mechanisms of immune activation and regulation, which is crucial for developing effective vaccines and immunotherapies.Aliases
Throughout her career, Misako Matsumoto has been referenced under various aliases, including M. Matsumoto, M Matsumoto, and Misak Matsumoto. However, Misako Matsumoto is her most comprehensive and formal name used in scientific publications.Publication and Citation Metrics
| Metric |
Count |
| Total Citation Count |
20,236 |
| H-index |
75 |
| Total Paper Count |
395 |
